Literature DB >> 33128136

Efficacy, safety, and user experience of DIY or open-source artificial pancreas systems: a systematic review.

N A M Asarani1, A N Reynolds2, M Elbalshy1, M Burnside3, M de Bock3, D M Lewis4, B J Wheeler5.   

Abstract

The do-it-yourself artificial pancreas system (DIYAPS) is a patient-driven initiative with the potential to revolutionise diabetes management, automating insulin delivery with existing pumps and CGM combined with open-source algorithms. Given the considerable interest in this topic within the diabetes community, we have conducted a systematic review of DIYAPS efficacy, safety, and user experience. Following recognised procedures and reporting standards, we identified 10 eligible publications of 730 participants within the peer-reviewed literature. Overall, studies reported improvements in time in range, HbA1c (glycated haemoglobin), reduced hypoglycaemia, and improved quality of life with DIYAPS use. While results were positive, the identified studies were small, and the majority were observational and at high risk of bias. Further research including well-designed randomised trials comparing DIYAPS with appropriate comparators is recommended.

Entities:  

Keywords:  Artificial pancreas; Do-it-yourself; Glucose sensing technology; Open-source

Year:  2020        PMID: 33128136     DOI: 10.1007/s00592-020-01623-4

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  3 in total

1.  Patient, study thyself.

Authors:  Paul Wicks
Journal:  BMC Med       Date:  2018-11-23       Impact factor: 8.775

2.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

3.  Efficacy and safety of a sodium-glucose co-transporter-2 inhibitor versus placebo as an add-on therapy for people with type 2 diabetes inadequately treated with metformin and a dipeptidyl peptidase-4 inhibitor: a systematic review and meta-analysis of randomised controlled trials.

Authors:  C De Buitléir; E O' Connor; M M Satti; J Shaw; A Liew
Journal:  Diabet Med       Date:  2020-11-28       Impact factor: 4.359

  3 in total
  8 in total

Review 1.  Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals.

Authors:  Katarina Braune; Rayhan A Lal; Lenka Petruželková; Gary Scheiner; Per Winterdijk; Signe Schmidt; Linda Raimond; Korey K Hood; Michael C Riddell; Timothy C Skinner; Klemens Raile; Sufyan Hussain
Journal:  Lancet Diabetes Endocrinol       Date:  2021-11-13       Impact factor: 32.069

2.  Large-Scale Data Analysis for Glucose Variability Outcomes with Open-Source Automated Insulin Delivery Systems.

Authors:  Arsalan Shahid; Dana M Lewis
Journal:  Nutrients       Date:  2022-05-02       Impact factor: 6.706

Review 3.  Closed-Loop Insulin Delivery Systems: Past, Present, and Future Directions.

Authors:  Sophie Templer
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-06       Impact factor: 6.055

4.  Use of automated insulin delivery systems in people with type 1 diabetes fasting during Ramadan: An observational study.

Authors:  Ali Aldibbiat; Ahmed Alqashami; Sufyan Hussain
Journal:  J Diabetes Investig       Date:  2021-12-15       Impact factor: 3.681

5.  Practical Guidance on Open Source and Commercial Automated Insulin Delivery Systems: A Guide for Healthcare Professionals Supporting People with Insulin-Requiring Diabetes.

Authors:  Dana M Lewis; Sufyan Hussain
Journal:  Diabetes Ther       Date:  2022-08-01       Impact factor: 3.595

Review 6.  Review of Automated Insulin Delivery Systems for Type 1 Diabetes and Associated Time in Range Outcomes.

Authors:  Armaan Nallicheri; Katherine M Mahoney; Hanna A Gutow; Natalie Bellini; Diana Isaacs
Journal:  touchREV Endocrinol       Date:  2022-05-20

7.  How It Started, How It Is Going: The Future of Artificial Pancreas Systems (Automated Insulin Delivery Systems).

Authors:  Dana Lewis
Journal:  J Diabetes Sci Technol       Date:  2021-07-05

Review 8.  Fault Tolerant Strategies for Automated Insulin Delivery Considering the Human Component: Current and Future Perspectives.

Authors:  Aleix Beneyto; B Wayne Bequette; Josep Vehi
Journal:  J Diabetes Sci Technol       Date:  2021-07-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.